FDA approves Luxturna gene therapy for biallelic RPE65 mutation-associated retinal dystrophy Dec. 20, 2017
FDA approves Isentress for the treatment of HIV-1 infection in newborns weighing at least 2 kg Dec. 4, 2017
RSS